Member access

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  Grifols SA    GRF   ES0171996012

GRIFOLS SA (GRF)

58
Delayed Quote. Delayed CHI-X - 03/31 05:35:57 am
40.388 EUR   +0.87%
03/30 GRIFOLS : In Clayton, a push for PB&J
03/29 GRIFOLS : to make a major equity investment in Alkahest
03/09 GRIFOLS : to make a major equity investment in Alkahest
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
03/24/2015 03/25/2015 03/26/2015 03/27/2015 03/30/2015 Date
40.78(c) 39.95(c) 39.25(c) 39.385(c) 40.04(c) Last
1 132 781 1 357 121 2 557 990 800 460 478 790 Volume
+0.49% -2.04% -1.75% +0.34% +1.66% Change
More quotes
Financials (€)
Sales 2015 3 759 M
EBIT 2015 930 M
Net income 2015 537 M
Debt 2015 2 997 M
Yield 2015 1,64%
Sales 2016 4 045 M
EBIT 2016 1 046 M
Net income 2016 618 M
Debt 2016 2 854 M
Yield 2016 1,89%
PER 2015 24,00
PER 2016 21,11
EV / Sales 2015 4,14x
EV / Sales 2016 3,81x
Capitalization 12 576 M
More Financials
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
05/05Earnings Release
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Latest news on GRIFOLS SA
03/30 GRIFOLS : In Clayton, a push for PB&J
03/29 GRIFOLS : to make a major equity investment in Alkahest
03/09 GRIFOLS : to make a major equity investment in Alkahest
03/04 GRIFOLS : to make a major equity investment in Alkahest Download (380.5 Kb)
03/02DJNovartis, GlaxoSmithKline Complete Series of Deals - Update
03/02DJNovartis, GlaxoSmithKline Complete Deals
03/02DJNovartis, GlaxoSmithKline Complete Series of Deals
02/26 GRIFOLS : achieves a record net profit of 470.3 million euros with growth of 36...
More news
Sector news : Biopharmaceuticals
02:06a BAYER : HealthCare Expands Collaboration with Broad Institute of MIT and Harvard..
01:31a KYOWA HAKKO KIRIN : Completion of Construction for New Research Building in Fuji..
03/30 ACTAVIS : Amneal Signs Deal to Acquire the Generic Business of Actavis Australia
More sector news : Biopharmaceuticals
News from SeekingAlpha
03/02 TIGENIX : Locked And Loaded For Phase 3 Readout
02/23 Tracking John Paulson's Paulson & Company Portfolio - Q4 2014 Update


Comments 
Advertisement
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | GRF | ES0171996012 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF